Atlas Trials

A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease

Clinical trial NCT06609889 · RECRUITING

Trial details

NCT number
NCT06609889
Sponsor
Berge Minassian
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lafora Disease
Start date
2024-12-03
Primary completion
2027-10-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.